Search
-
News
A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone marrow transplants for blood cancer.
… Friday, September 28, 2018 Bottom Line: A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone
-
News
Take a short quiz to test your knowledge of breast cancer screening.
… Tuesday, October 3, 2017 Summary Does breast cancer screening hurt? How often should you get a mammogram? Get the answers to these questions and more by taking this quiz. It can be hard to stay on top of current breast cancer screening guidelines because the advice is sometimes confusing or conflicting
-
News
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.
… Thursday, November 18, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute
-
News
Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.
… Friday, January 13, 2012 Summary Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy. Researchers at Memorial Sloan Kettering have shown the usefulness of a scale
-
News
The research focused on sclerosing stromal tumor, a rare, benign ovarian tumor that is not cancer but can be misdiagnosed as cancer.
… Monday, January 27, 2020 Summary Investigators are studying a rare ovarian tumor called sclerosing stromal tumor, a benign tumor that can be misdiagnosed as cancer. As research has revealed more about the genomics of cancer, it’s changed the way that doctors think about the disease. There is not a single
-
News
A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.
… Saturday, October 1, 2011 Summary A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells. In 2008, two research groups in Europe made
-
2023 Annual Report
In 2023, the MSK Giving community raised a record-breaking $1 billion — 100% of which will support our mission of ending cancer for life.
… Monday, June 10, 2024 In 2023, the MSK Giving community raised a record-breaking $1 billion — 100% of which will support our Memorial Sloan Kettering Cancer Center (MSK) mission of ending cancer for life . Every single member of the MSK Giving community was key to this historic success. “We are the most
-
News
A large study that analyzed nearly 120,000 cells in a developing mouse embryo is full of surprises.
… Monday, April 8, 2019 Summary Scientists in the Sloan Kettering Institute have combined powerful laboratory and computational techniques to analyze the earliest moments of mouse development. The results could help explain why cancers form more commonly in certain places than in others. To a developmental
-
News
Take a look back at some of the biggest science stories from this past year.
… Tuesday, December 21, 2021 The aim of the Sloan Kettering Institute (SKI) at Memorial Sloan Kettering Cancer Center is to pursue the best biological science wherever it leads. This past year, SKI scientists made groundbreaking discoveries across the biomedical spectrum — from how proteins function at
-
News
On November 3, 2021, a panel of MSK doctors joined The Abyssinian Baptist Church for an educational webinar about COVID-19 vaccination.
… Thursday, November 11, 2021 On November 3, 2021, a panel of MSK doctors joined Linda Thompson, leader of the Abyssinian Baptist Church’s Health Ministry, in an educational webinar to discuss questions about COVID-19 vaccination and address common myths and misconceptions about the vaccine. The panel